secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2022-05-03T23:59:59+00:00
Accession:  0001638833-22-000094
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q1 revenue $596.2M (+16.4%), net income $12.2M; raises FY2022 guidance
--------------------------------------------------------------------------------

- Revenue $596.2M (+16.4% YoY); net income $12.2M vs prior-year net loss $31.3M.
- Days adjusted same-facility revenue +8.2%, case volume +6.3% vs prior-year quarter.
- Adjusted EBITDA $77.1M (+5.8% YoY); ex-CARES grants $76.1M (+22.3% YoY).
- Raised FY2022 guidance: revenue $2.5-2.6B, Adjusted EBITDA $375-385M.
- Finalized partnership with ValueHealth; acquired three ASCs and four ortho-focused de novos.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000094/0001638833-22-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000094/sgry-20220503.htm
  HTML page:      https://secwatch.observer/filing/0001638833-22-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer